Society for Neuroscience (SfN)

@SfNtweets · Washington, DC · joined 11 May 2009

The largest nonprofit of scientists & physicians devoted to understanding the #brain & #nervoussystem. Follow us at @NeuronlineSfN, @SfN_Events & @SfNJournals

244 980Followers

320Following

22 792Posts total

12.5KViews on collected posts

Ultimi post

Society for Neuroscience (SfN)@SfNtweets22 Sep

Peer review scores and percentiles help applicants understand funding decisions. The NIH's new proposed changes could take that transparency away. Stand with fellow #NeuroAdvocates and submit a public comment by October 13. 🔗 https://t.co/dvin8qcY5N #NeuroTwitter https://t.c

2K views · 8 likes · 4 reposts · 0 replies Open on X →

Society for Neuroscience (SfN)@SfNtweets21 Sep

https://t.co/EB6e2PnbRe is getting an update! Help us understand how our site can better serve you. Take our short survey for a chance to win an annual meeting registration, a 2027 membership, or a $100 gift card. Survey closes Oct. 2, 5 p.m. EDT. 🔗 https://t.co/z9ZuDPgj4z ht

2.6K views · 3 likes · 3 reposts · 0 replies Open on X →

Society for Neuroscience (SfN)@SfNtweets18 Sep

Have ideas to strengthen the National Science Foundation? SfN has partnered with @APSphysics on NSF Forward to shape policy recommendations for the 120th Congress. What should NSF keep, change, stop, or start doing? Share your ideas by Sept 21. 🔗 https://t.co/suHjkfufCN 2.7K views · 3 likes · 2 reposts · 1 replies Open on X →

Society for Neuroscience (SfN)@SfNtweets17 Sep

@SfNtweets The publishing angle raises a real question: how do we validate AI-assisted synthesis without reinforcing citation bias? I’ve been thinking about this with Sci-Quest, a platform for biomedical literature reviews: https://t.co/AMUYFvZ8PU 13 views · 0 likes · 0 reposts · 0 replies Open on X →

Society for Neuroscience (SfN)@SfNtweets16 Sep

Explore how AI is reshaping neuroscience, ethics, and scientific publishing. Register now 🔗 https://t.co/rFHxjVbioJ #NeuroTwitter #AcademicTwitter #SciTwitter https://t.co/oXGt7cTMEo

2.8K views · 8 likes · 2 reposts · 1 replies Open on X →

Society for Neuroscience (SfN)@SfNtweets15 Sep

This #HispanicHeritageMonth, SfN celebrates the Hispanic and Latino neuroscientists whose research, mentorship, & leadership are advancing our understanding of the brain. What sparked your interest in neuroscience? #NeuroTwitter #SciTwitter #AcademicTwitter #MedTwitter https://

2.3K views · 6 likes · 4 reposts · 1 replies Open on X →

Rispetto ad account della stessa dimensione

6 post degli ultimi 90 giorni, accanto alla fascia di 100K–1M follower. sotto i pari sia per copertura sia per interazione.

Visualizzazioni mediane2 450questo account6 360mediana per 100K–1M

Copertura, %1.00%questo account1.64%mediana per 100K–1M

Interazione, %0.31%questo account0.97%mediana per 100K–1M

Metrica	Questo account	Mediana per 100K–1M	Rapporto
Visualizzazioni mediane per post	2 450	6 360	0.39×
Copertura (visualizzazioni ÷ follower)	1.00%	1.64%	0.61×
Tasso di interazione	0.31%	0.97%	0.32×

Altri account di questa fascia → Confronta con un altro account → Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.3K15 Sep

2.8K16 Sep

1317 Sep

2.7K18 Sep

2.6K21 Sep

2K22 Sep

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.48%15 Sep

0.39%16 Sep

0.00%17 Sep

0.22%18 Sep

0.23%21 Sep

0.61%22 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.97%.

What the audience does

Likes53.8%28 in total

Reposts28.8%15 in total

Replies5.8%3 in total

Bookmarks11.5%6 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.